PPARG and Insulin resistance: For example, rosiglitazone dampens the expression of pigment epithelium-derived factor (PEDF), a driver of insulin resistance, in hepatocytes and adipocytes by activating AMP-activated protein kinase (AMPK) rather than PPARγ [29].